tumor cells are unable to synthesize arginine due to argininosuccinate synthetase 1 (ASS1) deficiency, and instead upregulate insulin-like growth factor 1 (IGF-1R) and enhance ASS1 transcription via c-MYC for arginine metabolic reprogramming. This evidence concerns the gene MYC and neoplasm.